Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2001;32:1750-1758

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sairanen, T.
Right arrow Articles by Cechetto, D. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sairanen, T.
Right arrow Articles by Cechetto, D. F.
Related Collections
Right arrow Apoptosis
Right arrow Growth factors/cytokines
Right arrow Acute Cerebral Infarction
Right arrow Pathology of Stroke

(Stroke. 2001;32:1750.)
© 2001 American Heart Association, Inc.


Original Contributions

Evolution of Cerebral Tumor Necrosis Factor-{alpha} Production During Human Ischemic Stroke

Tiina Sairanen, MD; Olli Carpén, MD, PhD; Marja-Liisa Karjalainen-Lindsberg, MD, PhD; Anders Paetau, MD, PhD; Ursula Turpeinen, PhD; Markku Kaste, MD, PhD Perttu J. Lindsberg, MD, PhD

From the Department of Clinical Neurosciences, Helsinki University Central Hospital (T.S., M.K., P.J.L.); Department of Pathology, Haartman Institute (T.S., O.C., M.-L.K.-L., A.P.); Laboratory, Helsinki University Central Hospital (U.T.); and Neuroscience Program, Biomedicum (M.K., P.J.L.), Helsinki, Finland.

Reprint requests to Dr Tiina Sairanen, Department of Clinical Neurosciences, Helsinki University Central Hospital, Haartmaninkatu 4, FIN-00290 Helsinki, Finland. E-mail Tiina.sairanen{at}helsinki.fi

Background and Purpose— Tumor necrosis factor-{alpha} (TNF-{alpha}) is detected in ischemic brain cells in experimental animal models and is believed to play an important role in apoptosis. However, the natural expression of TNF-{alpha} during human stroke is not known.

Methods— We examined TNF-{alpha} immunohistochemistry and terminal deoxynucleotidyl transferase–mediated dUTP nick-end labeling (TUNEL) in brain samples of stroke victims (n=16) after variable survival (15 hours to 18 days). Systemic TNF-{alpha} content from a separate cohort including severe or lethal stroke cases (n=26) was also assayed.

Results— Neuronal TNF-{alpha} was demonstrated from 0.6 to 5.4 days after the onset of stroke symptoms, peaking bilaterally during days 2 and 3. Bilateral glial TNF-{alpha} immunoreactivity was detected during the acute phase, with the astrocytic TNF-{alpha} expression dominating in later phases and persisting contralaterally to the infarct in more matured phases (17 to 18 days). Invading inflammatory cells were TNF-{alpha} immunopositive beginning on the third day. Besides, vascular wall structures showed immunoreactivity sporadically. TNF-{alpha} levels were mostly nondetectable in peripheral blood. TUNEL labeling and TNF-{alpha} staining overlapped, although not completely, during the first days.

Conclusions— The data support the hypothesis that TNF-{alpha} may be involved both in the acute propagation of inflammatory processes and cell death and possibly in the more delayed reconstitutive processes of human ischemic stroke.

Editorial Comment

David F. Cechetto, PhD; Guest Editor

Department of Anatomy and Cell Biology, University of Western Ontario, London, Ontario, Canada




This article has been cited by other articles:


Home page
IOVSHome page
S. Berger, S. I. Savitz, S. Nijhawan, M. Singh, J. David, P. S. Rosenbaum, and D. M. Rosenbaum
Deleterious Role of TNF-{alpha} in Retinal Ischemia-Reperfusion Injury
Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3605 - 3610.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
O. Baranova, L. F. Miranda, P. Pichiule, I. Dragatsis, R. S. Johnson, and J. C. Chavez
Neuron-Specific Inactivation of the Hypoxia Inducible Factor 1{alpha} Increases Brain Injury in a Mouse Model of Transient Focal Cerebral Ischemia
J. Neurosci., June 6, 2007; 27(23): 6320 - 6332.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. E. Iosif, C. T. Ekdahl, H. Ahlenius, C. J. H. Pronk, S. Bonde, Z. Kokaia, S.-E. W. Jacobsen, and O. Lindvall
Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis.
J. Neurosci., September 20, 2006; 26(38): 9703 - 9712.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. Y. Cheranov and J. H. Jaggar
TNF-{alpha} dilates cerebral arteries via NAD(P)H oxidase-dependent Ca2+ spark activation
Am J Physiol Cell Physiol, April 1, 2006; 290(4): C964 - C971.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
T. Sairanen, M.-L. Karjalainen-Lindsberg, A. Paetau, P. Ijas, and P. J. Lindsberg
Apoptosis dominant in the periinfarct area of human ischaemic stroke--a possible target of antiapoptotic treatments
Brain, January 1, 2006; 129(1): 189 - 199.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. C. Fagan, D. C. Hess, E. J. Hohnadel, D. M. Pollock, and A. Ergul
Targets for Vascular Protection After Acute Ischemic Stroke
Stroke, September 1, 2004; 35(9): 2220 - 2225.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. Nurmi, P. J. Lindsberg, M. Koistinaho, W. Zhang, E. Juettler, M.-L. Karjalainen-Lindsberg, F. Weih, N. Frank, M. Schwaninger, and J. Koistinaho
Nuclear Factor-{kappa}B Contributes to Infarction After Permanent Focal Ischemia
Stroke, April 1, 2004; 35(4): 987 - 991.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. H. Rainer, L. K.S. Wong, W. Lam, E. Yuen, N. Y.L. Lam, C. Metreweli, and Y.M. D. Lo
Prognostic Use of Circulating Plasma Nucleic Acid Concentrations in Patients with Acute Stroke
Clin. Chem., April 1, 2003; 49(4): 562 - 569.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Akassoglou, E. Douni, J. Bauer, H. Lassmann, G. Kollias, and L. Probert
Exclusive tumor necrosis factor (TNF) signaling by the p75TNF receptor triggers inflammatory ischemia in the CNS of transgenic mice
PNAS, January 21, 2003; 100(2): 709 - 714.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Castellanos, J. Castillo, M. M. Garcia, R. Leira, J. Serena, A. Chamorro, and A. Davalos
Inflammation-Mediated Damage in Progressing Lacunar Infarctions: A Potential Therapeutic Target
Stroke, April 1, 2002; 33(4): 982 - 987.
[Abstract] [Full Text] [PDF]